
Journal of International Oncology ›› 2026, Vol. 53 ›› Issue (3): 137-143.doi: 10.3760/cma.j.cn371439-20250627-00022
• Original Article • Previous Articles Next Articles
Received:2025-06-27
Online:2026-03-08
Published:2026-02-09
Contact:
Cui Qin
E-mail:cuiqin2010luck@126.com
Supported by:Qu Zhenjie, Cui Qin. Research of the mechanism of lncRNA FGD5-AS1/miR-154-5p/WNT5A signaling pathway in regulating proliferation and migration of paclitaxel-resistant gastric cancer cells[J]. Journal of International Oncology, 2026, 53(3): 137-143.
| [1] |
Yasuda T, Wang YA. Gastric cancer immunosuppressive microenvironment heterogeneity: implications for therapy development[J]. Trends Cancer, 2024, 10(7): 627-642. DOI: 10.1016/j.trecan.2024.03.008.
pmid: 38600020 |
| [2] | Stroobant EE, Strong VE. Advances in gastric cancer surgical management[J]. Hematol Oncol Clin North Am, 2024, 38(3): 547-557. DOI: 10.1016/j.hoc.2024.01.003. |
| [3] | Kim SE, Park MI, Lee MH. Chemotherapy for metastatic gastric cancer[J]. Korean J Gastroenterol, 2025, 85(1): 1-10. DOI: 10.4166/kjg.2024.139. |
| [4] |
Alkhathami AG, Pallathadka H, Shah S, et al. LncRNAs in modula-ting cancer cell resistance to paclitaxel (PTX) therapy[J]. Med Oncol, 2024, 42(1): 28. DOI: 10.1007/s12032-024-02577-1.
pmid: 39671022 |
| [5] | Alkhathami AG, Pallathadka H, Shah S, et al. Mechanisms behind the lncRNAs-mediated regulation of paclitaxel (PTX) resistance in human malignancies[J]. Exp Cell Res, 2025, 445(2): 114434. DOI: 10.1016/j.yexcr.2025.114434. |
| [6] | Coan M, Haefliger S, Ounzain S, et al. Targeting and engineering long non-coding RNAs for cancer therapy[J]. Nat Rev Genet, 2024, 25(8): 578-595. DOI: 10.1038/s41576-024-00693-2. |
| [7] | Modabber N, Mahboub SS, Khoshravesh S, et al. Evaluation of long non-coding RNA (lncRNA) in the pathogenesis of chemotherapy resistance in cervical cancer: diagnostic and prognostic approach[J]. Mol Biotechnol, 2024, 66(10): 2751-2768. DOI: 10.1007/s12033-023-00909-6. |
| [8] | He Z, Wang J, Zhu C, et al. Exosome-derived FGD5-AS1 promotes tumor-associated macrophage M2 polarization-mediated pancreatic cancer cell proliferation and metastasis[J]. Cancer Lett, 2022, 548: 215751. DOI: 10.1016/j.canlet.2022.215751. |
| [9] | Xia Z, Zhang L, Zhou H, et al. LncRNA-FGD5-AS1 promotes 5-Fu resistance of cervical cancer cells through modulating the miR-130a-3p-YTHDF2 axis[J]. J Chemother, 2025, 37(8): 710-722. DOI: 10.1080/1120009X.2024.2436803. |
| [10] |
Qin S, Liu Y, Zhang X, et al. lncRNA FGD5-AS1 is required for gastric cancer proliferation by inhibiting cell senescence and ROS production via stabilizing YBX1[J]. J Exp Clin Cancer Res, 2024, 43(1): 188. DOI: 10.1186/s13046-024-03103-x.
pmid: 38965605 |
| [11] | Hao M, Li T, Xiao L, et al. METTL3-induced FGD5-AS1 contri-butes to the tumorigenesis and PD-1/PD-L1 checkpoint to enhance the resistance to paclitaxel of endometrial carcinoma[J]. J Cell Mol Med, 2024, 28(5): e17971. DOI: 10.1111/jcmm.17971. |
| [12] | Fei D, Yuan H, Zhao M, et al. LncRNA FGD5-AS1 potentiates autophagy-associated doxorubicin resistance by regulating the miR-154-5p/WNT5A axis in osteosarcoma[J]. Cell Biol Int, 2022, 46(11): 1937-1946. DOI: 10.1002/cbin.11889. |
| [13] |
Amioka A, Kadoya T, Sueoka S, et al. Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer[J]. Breast Cancer, 2021, 28(5): 1062-1071. DOI: 10.1007/s12282-021-01241-0.
pmid: 34047951 |
| [14] | Harada K, Sakamoto N, Kitaoka T, et al. PI3 expression predicts recurrence after chemotherapy with DNA-damaging drugs in gastric cancer[J]. J Pathol, 2025, 265(4): 472-485. DOI: 10.1002/path.6400. |
| [15] | Xu J, Xu Y, Ye G, et al. LncRNA-SNHG1 promotes paclitaxel resistance of gastric cancer cells through modulating the miR-216b-5p-hexokianse 2 axis[J]. J Chemother, 2023, 35(6): 527-538. DOI: 10.1080/1120009X.2022.2157618. |
| [16] | Naseri B, Farsad-Akhtar N, Mardi A, et al. lncRNA PVT1 silencing inhibits gastric cancer cells' progression via enhancing chemosensitivity to paclitaxel[J]. Gene, 2025, 932: 148900. DOI: 10.1016/j.gene.2024.148900. |
| [17] | Tong KH, Qian J. Long non-coding RNA FGD5-AS1 is an inducer of cisplatin chemoresistance in gastric cancer cells by sponging miR-195[J]. J Biol Regul Homeost Agents, 2021, 35(2): 819-826. DOI: 10.23812/20-667-L. |
| [18] |
Brandl A, Prabhu A. Intraperitoneal chemotherapy in the treatment of gastric cancer peritoneal metastases: an overview of common therapeutic regimens[J]. J Gastrointest Oncol, 2021, 12(Suppl 1): S32-S44. DOI: 10.21037/jgo-2020-04.
pmid: 33968424 |
| [19] | Ye M, Xiu LJ, Ji QQ, et al. Research progress in targeted therapies for gastric cancer[J]. Int J Clin Pharmacol Ther, 2022, 60(12): 509-514. DOI: 10.5414/CP204250. |
| [20] | Usman RM, Razzaq F, Akbar A, et al. Role and mechanism of autophagy-regulating factors in tumorigenesis and drug resistance[J]. Asia Pac J Clin Oncol, 2021, 17(3): 193-208. DOI: 10.1111/ajco.13449. |
| [21] | Shetty A, Venkatesh T, Kabbekodu SP, et al. LncRNA-miRNA-mRNA regulatory axes in endometrial cancer: a comprehensive overview[J]. Arch Gynecol Obstet, 2022, 306(5): 1431-1447. DOI: 10.1007/s00404-022-06423-5. |
| [22] | Patel D, Thankachan S, Sreeram S, et al. LncRNA-miRNA-mRNA regulatory axes as potential biomarkers in cervical cancer: a comprehensive overview[J]. Mol Biol Rep, 2025, 52(1): 110. DOI: 10.1007/s11033-024-10215-2. |
| [1] | Li Yao, Tian Lin, Liu Haolin, Xiao Jing. Effects of lncRNA CASC19 on proliferation,migration and invasion of breast cancer cells by regulating miR-410-3p/LAMC1 signaling pathway [J]. Journal of International Oncology, 2026, 53(3): 129-136. |
| [2] | Ta Na, Han Yun, Long Rui, Hu Jun. Influence of the expression profile characteristics of APO and ILF on the surgical prognosis in patients with locally advanced gastric cancer [J]. Journal of International Oncology, 2026, 53(3): 150-156. |
| [3] | Ma Zhuaxiji, Min Xiyun, Guan Quanlin. Immune remodeling strategies and clinical progress of the transformation of gastric cold tumors into hot tumors [J]. Journal of International Oncology, 2026, 53(3): 182-186. |
| [4] | Zhang Long, Li Jianzhen, Zhang Wei. Mechanisms of invadopodia in tumor metastasis and frontiers in therapeutic translation [J]. Journal of International Oncology, 2026, 53(2): 100-104. |
| [5] | Laibijiang Wusiman, Song Dingding, Zhang Wenbin. Effect of SPART on the proliferation and migration capabilities of gastric cancer cell through lipophagy [J]. Journal of International Oncology, 2026, 53(2): 73-78. |
| [6] | Arya Ehmet, Nuriman Samat, Wang Tingting. Analysis of the correlation between nutritional status and preoperative gastric morphology and functional characteristics in patients with gastric cancer after radical gastrectomy [J]. Journal of International Oncology, 2026, 53(2): 87-92. |
| [7] | Yang Xinting, Ma Tengyu, Guan Shulong, Yang Mei, Jiang Zhou, Yang Xinru, Jiang Liangqian, Gao Meihua, Xu Yingjie, Cong Beibei. Research on the mechanism of targeting CD59 to inhibit proliferation, migration, and induce apoptosis in oral squamous cell carcinoma [J]. Journal of International Oncology, 2026, 53(1): 16-23. |
| [8] | Zhang Xiaoxi, Cheng Chunlai. Expression of ALDH6A1 in clear cell renal cell carcinoma and its impacts on proliferation, apoptosis, and invasion of renal cancer cells [J]. Journal of International Oncology, 2026, 53(1): 38-46. |
| [9] | Wang Yu, Li Yuanfei, Guo Yuntong. Research progress of the immunoscore system in gastric cancer [J]. Journal of International Oncology, 2026, 53(1): 62-64. |
| [10] | Liu Mei, Hu Yuchong, Li Fengtong, Chao Lemen, Liu Meng, Kang Linlin. Mechanism of action of SHCBP1 in malignant tumors and progress in clinical research [J]. Journal of International Oncology, 2025, 52(9): 583-586. |
| [11] | Li Guangxin, Quan Huijuan, Gao Zhijuan, Wang Xiaojun, Li Liang, Dong Qian, Miao Yongtao, Liu Dongsheng. Correlation between serum levels of HAMP, SPP1, RGS2 and clinical pathological characteristics of gastric cancer patients and their predictive value for postoperative recurrence or metastasis [J]. Journal of International Oncology, 2025, 52(8): 502-507. |
| [12] | Zhang Baihong, Yue Hongyun. Novel therapeutic strategies: targeting cancer metastasis [J]. Journal of International Oncology, 2025, 52(8): 528-531. |
| [13] | Liu Shan, Pan Yue, Zhang Zhuo, Liu Chong, Li Xueman, Xiong Fei. Inhibition of the growth, migration, and angiogenesis of esophageal squamous cell carcinoma by metformin by regulating ALKBH3 expression [J]. Journal of International Oncology, 2025, 52(6): 343-352. |
| [14] | Zhong Xiao, Li Butuo, Wang Linlin. Research progress of radiotherapy for brain metastases from ALK-positive NSCLC [J]. Journal of International Oncology, 2025, 52(6): 374-378. |
| [15] | Wang Yong, Wu Xinlin. Related molecular mechanisms of liver metastasis from colorectal cancer [J]. Journal of International Oncology, 2025, 52(6): 388-391. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
